Skip to main content

Table 3 Weight, length, and head circumference growth rates from 14 days to 30, 60, 90, and 120 days of age

From: Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial

Gender

Day

Group (n)

Growth rate*

Weight† (g/day)

Length (cm/day)

Head circumference (cm/day)

male

30

Control (74)

48.9 ± 1.5

0.15 ± 0.009

0.10 ± 0.005

  

PDX/GOS (68)

45.2 ± 1.5‡

0.15 ± 0.009

0.10 ± 0.005

  

GOS (68)

46.7 ± 1.6

0.13 ± 0.009

0.10 ± 0.005

 

60

Control (66)

41.3 ± 1.1

0.13 ± 0.004

0.08 ± 0.002

  

PDX/GOS (59)

41.4 ± 1.2

0.13 ± 0.004

0.07 ± 0.002

  

GOS (60)

41.9 ± 1.2

0.13 ± 0.004

0.07 ± 0.002

 

90

Control (62)

36.1 ± 1.0

0.12 ± 0.003

0.07 ± 0.002

  

PDX/GOS (55)

37.4 ± 1.0

0.12 ± 0.003

0.06 ± 0.002

  

GOS (52)

36.8 ± 1.1

0.12 ± 0.003

0.06 ± 0.002

 

120

Control (63)

32.6 ± 0.8

0.11 ± 0.002

0.06 ± 0.001

  

PDX/GOS (54)

34.0 ± 0.9

0.11 ± 0.002

0.06 ± 0.001

  

GOS (50)

33.3 ± 0.9

0.11 ± 0.002

0.06 ± 0.001

female

30

Control (52)

38.4 ± 1.5

0.15 ± 0.012

0.09 ± 0.006

  

PDX/GOS (50)

34.9 ± 1.6

0.12 ± 0.012

0.08 ± 0.007

  

GOS (49)

34.6 ± 1.6‡

0.11 ± 0.012

0.09 ± 0.007

 

60

Control (43)

32.4 ± 1.2

0.12 ± 0.005

0.07 ± 0.003

  

PDX/GOS (44)

32.1 ± 1.2

0.12 ± 0.005

0.06 ± 0.003

  

GOS (42)

32.2 ± 1.3

0.12 ± 0.006

0.07 ± 0.003

 

90

Control (40)

29.0 ± 1.0

0.11 ± 0.003

0.06 ± 0.002

  

PDX/GOS (43)

29.7 ± 0.9

0.11 ± 0.003

0.05 ± 0.002

  

GOS (38)

29.3 ± 1.0

0.11 ± 0.003

0.06 ± 0.002

 

120

Control (38)

27.6 ± 0.9

0.10 ± 0.003

0.05 ± 0.002

  

PDX/GOS (44)

27.9 ± 0.8

0.10 ± 0.002

0.05 ± 0.001

  

GOS (39)

27.3 ± 0.9

0.10 ± 0.003

0.05 ± 0.002

  1. * Mean ± standard error (SE).
  2. † Adjusted for body weight at enrollment.
  3. ‡ Significantly lower than Control, P < 0.05, one-tailed test.